Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 ...
Researchers have developed a novel combination therapy using an anticancer agent, mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating bacteria that are resistant to the ...
WEST LAFAYETTE, Ind. – Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the United States. An estimated 20,000 people in the U.S. become infected ...
To the Editor: The report by Ostrowsky et al. (May 10 issue) 1 provides evidence that active infection-control interventions can reduce or eliminate the transmission of vancomycin-resistant ...
In light of the scarcity of treatment options for VRE UTI and clinical data related to daptomycin use in this setting, the purpose of this report is to describe the clinical experience with daptomycin ...
Antibiotic exposure and dirty hands were factors linked to nursing home contamination with the multidrug-resistant bacteria vancomycin-resistant Enterococci, or VRE, a new study finds. The report was ...
A drug-resistant strain of bacteria inhabiting hospital settings has evolved to utilize an antimicrobial genetic tool. Vancomycin-resistant Enterococcus faecium (VREfm) is responsible for many lethal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results